This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Bone Metabolism Therapeutics Market To 2018 - Hyperparathyroidism Sector To Decline In The Absence Of New Product Launches And Increased Generic Erosion For Zemplar, Hectorol And Sensipar

Table 30: Osteoporosis Therapeutics Market, Global, Revenue Forecasts ($bn), 2010-2018 32

Table 31: Osteoporosis Therapeutics Market, Global, Revenue Analysis by Geography ($bn), 2002-2010 32

Table 32: Osteoporosis Therapeutics Market, Global, Revenue Analysis by Geography ($bn), 2010-2018 33

Table 33: Osteoporosis Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2010 35

Table 34: Osteoporosis Therapeutics Market, Global, Annual Cost of Treatment ($), 2010-2018 35

Table 35: Osteoporosis Therapeutics Market, Global, Treatment Usage Patterns (millions), 2002-2010 36

Table 36: Osteoporosis Therapeutics Market, Global, Treatment Usage Patterns (millions), 2010-2018 37

Table 37: Paget's Disease of Bone Therapeutics Market, Global, Revenue ($m), 2002-2010 41

Table 38: Paget's Disease of Bone Therapeutics Market, Global, Revenue Forecasts ($m), 2010-2018 41

Table 39: Paget's Disease of Bone Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2002-2010 42

Table 40: Paget's Disease of Bone Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2010-2018 43

Table 41: Paget's Disease of Bone Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2010 45

Table 42: Paget's Disease of Bone Therapeutics Market, Global, Annual Cost of Treatment ($), 2010-2018 45

Table 43: Paget's Disease of Bone Therapeutics Market, Global, Treatment Usage Patterns (millions), 2002-2010 46

Table 44: Paget's Disease of Bone Therapeutics Market, Global, Treatment Usage Patterns (millions), 2010-2018 47

Table 45: Hyperparathyroidism Therapeutics Market, Global, Revenue ($m), 2002-2010 51

Table 46: Hyperparathyroidism Therapeutics Market, Global, Revenue Forecasts ($m), 2010-2018 51

Table 47: Hyperparathyroidism Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2002-2010 52

Table 48: Hyperparathyroidism Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2010-2018 53

Table 49: Hyperparathyroidism Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2010 55

Table 50: Hyperparathyroidism Therapeutics Market, Global, Annual Cost of Treatment ($), 2010-2018 55

Table 51: Hyperparathyroidism Therapeutics Market, Global, Treatment Usage Patterns (millions), 2002-2010 56

Table 52: Hyperparathyroidism Therapeutics Market, Global, Treatment Usage Patterns (millions), 2010-2018 57

6 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs